Literature DB >> 28304233

PCSK9 Inhibition to Reduce Cardiovascular Events.

Robin P F Dullaart1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28304233     DOI： 10.1056/NEJMe1703138

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

Review 1.  Genome-Wide Association Studies of Coronary Artery Disease: Recent Progress and Challenges Ahead.

Authors:  Shoa L Clarke; Themistocles L Assimes
Journal:  Curr Atheroscler Rep       Date:  2018-07-18       Impact factor: 5.113

Review 2.  Monocyte-Macrophages and T Cells in Atherosclerosis.

Authors:  Ira Tabas; Andrew H Lichtman
Journal:  Immunity       Date:  2017-10-17       Impact factor: 31.745

Review 3.  Drug Therapy of Dyslipidemia in the Elderly.

Authors:  Srikanth Yandrapalli; Shashvat Gupta; Gabriela Andries; Howard A Cooper; Wilbert S Aronow
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

Review 4.  Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.

Authors:  Albert Selva-O'Callaghan; Marcelo Alvarado-Cardenas; Iago Pinal-Fernández; Ernesto Trallero-Araguás; José Cesar Milisenda; María Ángeles Martínez; Ana Marín; Moisés Labrador-Horrillo; Cándido Juárez; Josep María Grau-Junyent
Journal:  Expert Rev Clin Immunol       Date:  2018-02-23       Impact factor: 4.473

5.  A Mendelian randomization study of the effects of blood lipids on breast cancer risk.

Authors:  Christoph Nowak; Johan Ärnlöv
Journal:  Nat Commun       Date:  2018-09-27       Impact factor: 14.919

Review 6.  The cell biology of the hepatocyte: A membrane trafficking machine.

Authors:  Ryan J Schulze; Micah B Schott; Carol A Casey; Pamela L Tuma; Mark A McNiven
Journal:  J Cell Biol       Date:  2019-06-14       Impact factor: 10.539

7.  Elimination of Ox-LDL through the liver inhibits advanced atherosclerotic plaque progression.

Authors:  Zhiwen Wang; Xiaopeng Guo; Qing Zhang; Gaohui Du; Zhuanglin Zeng; Chuansheng Zheng; Yumiao Wei
Journal:  Int J Med Sci       Date:  2021-09-09       Impact factor: 3.738

8.  The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation.

Authors:  Zhiwen Wang; Juan Chen; Zhuanglin Zeng; Qing Zhang; Gaohui Du; Xiaopeng Guo; Yumiao Wei
Journal:  Mol Med       Date:  2022-03-02       Impact factor: 6.354

9.  Characterization of the CDAA Diet-Induced Non-alcoholic Steatohepatitis Model: Sex-Specific Differences in Inflammation, Fibrosis, and Cholesterol Metabolism in Middle-Aged Mice.

Authors:  Dániel Kucsera; Viktória E Tóth; Dorottya Gergő; Imre Vörös; Zsófia Onódi; Anikó Görbe; Péter Ferdinandy; Zoltán V Varga
Journal:  Front Physiol       Date:  2021-02-22       Impact factor: 4.566

10.  Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels and Cardiometabolic Risk Factors: A Population-Based Cohort Study.

Authors:  Jie Shi; Xiaoyong Li; Weiwei Zhang; Yixin Niu; Ning Lin; Hongmei Zhang; Guang Ning; Jiangao Fan; Li Qin; Qing Su; Zhen Yang
Journal:  Front Cardiovasc Med       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.